T-Zone AC Thyol Patch
SKU: 20
Hurry up! Sales Ends In
Hurry! Only 0 Left in Stock!
EFFECTIVE TREATMENT FOR ACNET-zone AC Thyol Patch is a hydro-matrix plaster that provides effective and intensive care for people who suffer from acne problems on the forehead. While its hydrogel structure helps moisturize the treated area, the unique formulation of the AC Thyol Patch treats your pimples effectively against bacterial and fungal infections. Antimicrobial / anti-inflammatory / anti-sebum effect
Arnica extract, salicylic acid, tea tree oil, ichthammol, olive leaf extract,
Zinc oxide, lactic acid, glycolic acid and sea buckthorn extract
Pore-shrinking effect Green Tea Extract & Grapefruit Extract
Antioxidant effect
Tocopheryl acetate
|
 |
 |
ADVANTAGESRegistered as a medical device (CE) in Europe. With ISO certificate for safety and quality. The effectiveness has been clinically proven by Derma Test.
DeliveryYou receive 2 boxes with a total of 8 T-zone AC Thyol patches.
|
Active Ingredients1,3 buthylene glycol, hyaluronic acid, arnica extract, salicylic acid, tea tree oil, ichthammol, olive leaf extract, zinc oxide, lactic acid, glycolic acid and sea buckthorn extract, green tea extract and grapefruit extract, tocopheryl acetate
INDICATIONHydrogel-matrix plasters for the prevention and treatment of inflammation and bacteria as well as mycotic infections of the skin ("pimples").
|
 |
HOW TO USE
(The patch can be used for a maximum of 8 hours. It is recommended to use it overnight for maxiumum effect.) |
CLINICAL STUDYTest subjects: 20 adult female and male test subjects with pimples in the facial area between the ages of 20 and 33 years
Application period: 4 weeks (once a day for 8 hours)
1) Visual assessment results of suitability for use for Acne-prone skin with GAGS (Global Acne Grading System)
Compared to before using the AC Thyol Patch, the GAGS (acne) classification score was reduced by 15.58%. After 4 weeks of use by a total of 19.48%
2) Evaluation results of sebum using the sebum meter method
Compared to before using the AC Thyol Patch, the amount of sebum reduced by 23.72%. After 4 weeks of use by a total of 39.68%.
The study was carried out by "Derma Test".
|
World-class approved hydrogel patches
Registration for Class 1 medical devices completed in Europe
our promise
Labottach promises to always only offer its customers safe and effective products that are strictly clinically approved.
We only use highly effective and mild components that can minimize skin problems and maximize the effects.
No use of parabens, artificial pigments, dimenthicon, formaldehyde and phthalate.
Wooshin Labottach continues to conduct clinical studies to guarantee the effectiveness and high quality of our products
Dermatest Germany is a research institute founded in Germany in 1978 in which companies and researchers work together in the field of skin care with public trust.
Dermatest is known for its strict standards and highly reliable procedures. Carrying out skin stimulation tests on humans.
The skin test results are certified at the highest level across the entire "Labottach hydrogel plaster" series.
"Very good" rating
Dermatest certificates for each product:
Clinical studies from around the world
Registration for European Class 2 Medical Devices completed
USA FDA registration completed
EXCELLENT MANUFACTURING PROCESS
Labottach's own factory in Korea and Slovenia
ISO certified facility
GMP & HACCP certified
LABOTTACH RESEARCH AND DEVELOPMENT CENTER
Seoul, South Korea
Quality, safety and customer satisfaction
We develop the best solution for excellent quality and safe products for high customer satisfaction with strict quality control discipline
International experts
Professional Research and Development Center Consisting of 11 Pharmacology Masters PhD holders from all over the world,
including Malaysia, China, Taiwan, Nepal, Korea and others.
Wooshin Labottach researchers achieve research results in various areas.
From cosmetics to state-of-the-art pharmaceuticals with high technology through consistent research and development.
Insight into our research center in South Korea
Other also bought
